West Pharmaceutical Services Inc.

١٦ نوفمبر

The stock is very clear, forming a downward trend that has been tested multiple times. As you can see, the strength of the recent decline is evident. The current price of the stock is $314.5. The sell entry point is at this level. Our first target is a new low below $265, and our second target is a low below $205.